Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE MKT LLC:BTX)

3.23
Delayed Data
As of Mar 23
 +0.08 / +2.54%
Today’s Change
2.26
Today|||52-Week Range
4.01
-10.53%
Year-to-Date
No recent news for BioTime Inc.

Today’s Trading

Previous close3.15
Today’s open3.11
Day’s range3.10 - 3.32
Volume435,884
Average volume (3 months)345,594
Market cap$349.2M
Dividend yield--
Data as of 4:00pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-208.82%
Earnings growth (next 5 years)--
Revenue growth (last year)-15.82%
P/E ratio9.5
Price/Sales60.68
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
SYRSSyros Pharmaceutical...-0.25-1.69%
RXDXIgnyta Inc+0.45+5.33%
PDLIPDL BioPharma Inc-0.02-0.98%
BOLDAudentes Therapeutic...-0.04-0.26%
Data as of 3:59pm ET, 03/23/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$5.9M
Annual profit (last year)$33.6M
Net profit margin566.81%

Profile

Sector
Health Technology
Industry
Medical Specialties
Co-President, Co-CEO &
Director
Michael D. West
Co-President, Co-CEO &
Director
Aditya P. Mohanty
Corporate headquarters
Alameda, California

Forecasts


Search for Jobs